GCGraeme O' Connor

Graeme O' Connor

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Graeme O' Connor has a total of 63 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Food-based enteral formulas in pediatric clinical practice: an expert opinion

    by Graeme O’COnnor, Antonella Diamanti, Chiara Maria Trovato, Claudio Romano, Gerard J. Minor, Guy Letellier, Koen Huysentruyt, Lisa M. Epp, Randi Tobberup, Sarah Durnan, et al.

    1. Enteral nutrition (EN) is the preferred route of nutritional support for children who are unable to meet their nutritional requirements orally with a functioning gastrointestinal (GI) tract [1]....

  • Factors Impacting Laxative Use in Children and Adolescents With Epidermolysis Bullosa: Single Centre Retrospective Study

    by Isabella Cotton, Natalie Yerlett, Pablo Lopez Balboa, Gabriella Petrof, Sumaiya Alauddin, Maria Bageta, Anna E. Martinez, Graeme O'COnnor

    Aim: Epidermolysis bullosa (EB) is characterised by chronic cutaneous wounds and gastrointestinal complications, including constipation. Aim to identify factors that impacted stool frequency and laxative use in paediatric patients with severe subtypes of EB. Methods: Retrospective data collection on demographics, type of EB, total fibre intake (food, enteral formula and supplements), probiotic supplementation, laxative use, iron supplementation, opioid‐based pain medication, stool consistency and frequency using the Bristol Stool Chart. Results: Data collected on 37 patients. The mean total fibre intake was 16.67 g/day (10.67 SD). Twenty‐seven of 37 (73%) children were on macrogol osmotic laxatives. Children who were taking fibre supplementation were also more likely to be on macrogol compared to children not taking fibre supplementation ( p = 0.047). No significant association was found between total fibre intake g/day or fibre reference nutrient intake (%) on stool consistency, r = −0.04 and r = −0.3, respectively. Children taking iron supplements were more likely to take macrogol compared to children not on iron supplements. Eight of 37 patients were on regular probiotics, but there was not a significant reduction in the need for macrogol osmotic laxatives compared to children not taking probiotics ( χ 2 0.025, p ‐value 0.87). Conclusion: Patients who were on fibre supplementation were also more likely to take laxatives. Patients on iron supplements had a greater reliance on laxatives than those patients not taking iron supplements, further demonstrating the impact iron has within the intestines. The potential benefits of probiotics in the management of constipation may be suppressed in children with EB due to regular antibiotic administration.

  • Feeding practices and nutritional management of infants with transient and congenital hyperinsulinism: A tertiary single‐center retrospective study

    by Lauren Cheng, Graeme O'COnnor, Emma Harris, Annaruby Cunjamalay, Antonia Dastamani

    Background and Aims: Hyperinsulinism (HI) is the most common cause of persistent neonatal hypoglycemia and requires careful nutritional management to maintain glycemic stability. Infants with transient hyperinsulinism (THI) often recover within months, whereas congenital hyperinsulinism (CHI) frequently requires prolonged medical and nutritional support. This study aimed to compare feeding practices and nutritional management of infants with THI and CHI. Methods: This single‐center retrospective study included infants diagnosed with HI under 12 months of age between January 2020 and January 2023. Infants were classified as THI if diazoxide was discontinued within six months and as CHI if treatment continued beyond six months. Data was collected at baseline and at one, three, and six months post‐diagnosis, with an additional one‐year follow‐up for the CHI group. Results: Ninety‐six infants were included (THI n = 74, CHI n = 22). 78% of the THI group and all infants with CHI required support from intravenous dextrose and/or parenteral nutrition at diagnosis. The CHI group demonstrated greater use of glucose polymers, high‐energy and hydrolyzed formulas by six months. By six months, 95% of the THI group were exclusively orally fed compared with 59% in the CHI group. Breastfeeding rates were low in both groups, declined over time and did not recover after medication was stopped. Conclusions: Infants with CHI require more prolonged and complex nutritional management, characterized by sustained reliance on tube feeding and higher carbohydrate feeds. Early optimization of nutritional intake and clearer strategies to support breastfeeding are areas for improving clinical management and feeding outcomes of infants with THI and CHI.

  • Open Access

    Case Report: Food-based enteral formula in the nutritional management of children with hyperinsulinism: single center retrospective case series

    by Graeme O’connor, Lauren Cheng, Annaruby Cunjamalay

    Context: Hyperinsulinism is characterized by dysregulated insulin secretion and is typically associated with reduced fasting tolerance. Long-term hyperinsulinism management includes nutrition and medication to normalize plasma glucose levels. Management of enteral feeds and oral intake is integral to the clinical management strategy in children with hyperinsulinism. A new generation of commercial Food Based Enteral Formulas (FBF) consists of rehydrated food, whole‐food protein sources and a mixture of soluble and insoluble fiber.Objective: Review the tolerance of a food-based enteral formula for the nutritional management of children with hyperinsulinism.Methods: A single-center retrospective case series to explore the dietetic practice of prescribing a commercially available FBF (Compleat® pediatric, Nestlé Health Science) in children with congenital hyperinsulinism (CHI) or postprandial hypoglycemia (PPH). Data were collected on demographics, gastrointestinal symptoms, anthropometrics, percentage glucose management indicators (GMI%) and hypo/hyperglycemic episodes.Results: Data were collected on eight children; six were diagnosed with CHI and two children had PPH. The mean age was 1.4 years (0.4SD). All children had a gastrostomy for enteral nutrition. Six of the eight children were prescribed proton pump inhibitors or stool softeners to manage gastroesophageal reflux and/or constipation symptoms. Within one month of children being prescribed FBF dietitians documented an 80% improvement in gastrointestinal symptoms. Dexcom glucose data was available for six children. Six months after FBF was prescribed, Dexcon Inc. data reported that five children had an improvement or stable GMI% and all six children had a reduction in hyperglycemic episodes (chi-square =5.8, p-value 0.02). Children prescribed FBF were less likely to require a glucose polymer (Chi-square = 4.9, p-value = 0.02).Conclusion: Our retrospective case series suggests that FBF is well tolerated in children with hyperinsulinism and may mitigate gut motility issues associated with hyperinsulinism, especially in relation to gastro-esophageal reflux and constipation symptoms. Furthermore, FBF may help reduce the dependency on glucose polymers and reduce the likelihood of a hyperglycemic episode. A larger sample size and longer follow-up study are necessary to substantiate the potential beneficial impact of FBF’s on glucose control in children with hyperinsulinism.


  • A pilot study to explore children’s experiences of intensive care post-cardiac arrest using art-based participatory methods

    by Donna Thomas, Graeme O’cOnnor

    Children who have survived a cardiac arrest are at the highest risk of long-term impairment, collectively termed Post Intensive Care Syndrome (PICS). This study aimed to explore through participatory and creative methods, children and young people’s (CYP) experiences post-cardiac arrest intensive care. Participatory research includes drawing, painting and small-world play. CYPs were recruited who had been admitted to intensive care post-cardiac arrest and had the cognitive and physical ability to talk, draw, paint or play out their experiences. Seven CYPs and families consented to participate. The median number of interviews was two (IQR2,3), with a median interview length of 24 minutes (IQR15,65 minutes). Themes that emerged: gratitude, distrust and extrasensory experiences. Four of the seven (57%) participants opted to paint or draw to convey their experiences. Two (28%) participants had no memories of their cardiac arrest or time in intensive care but used creative methods to express gratitude to the care team. Participatory research methods may be an effective way for CYPs to convey their experiences of post-cardiac arrest intensive care. CYPs who have been critically ill have expressed a need to make sense of their experiences in intensive care. Healthcare professionals should be aware that these experiences may be deemed as extrasensory and require sensitive exploration.

  • Exploring Dietitians' Experience of Blended Tube Feed in Paediatric Inpatient Settings: National Cross‐Sectional Survey, United Kingdom

    by Graeme O'COnnor, Shelley Cleghorn, Maleena Salam, Kelly Watson

    Background: Enteral tube feeding is used for children who are unable to meet their nutritional requirements orally. Gastrointestinal symptoms are some complications that can occur in enteral tube‐fed patients. Blended tube feeds (BTFs) for children who are gastrotomy tube‐fed have significantly increased in the last decade. BTF refers to homemade food that has been liquidised for enteral tube feeds. An increasing amount of evidence suggests that children on BTF have improved feed tolerance. It is unknown whether children admitted to a hospital established on a BTF can continue a BTF due to the potential barriers such as catering processes, staffing hours (limited to syringe bolus feeding) and food safety concerns. This national cross‐sectional survey aimed to explore the use of BTF in a paediatric hospital setting.Methods: This was a prospective, cross‐sectional, practice‐based survey of registered paediatric dietitians who work in an inpatient care setting to explore the use of BTF. The final survey consisted of 13 questions and took dietitians approximately 15 min to complete. The questions focused on the dietitian's experience, knowledge and confidence in children on a BTF.Results: Across the United Kingdom, 51 hospitals completed the survey. Of these, 16 of 19 were specialist children's hospitals (79% response rate) and 35 of 89 were general paediatric hospitals (39% response rate). All responders were paediatric dietitians. 49 of 51 (96%) dietitians knew of the British Dietetic Association (BDA) Practice Toolkit for Blended diets. Dietitians were asked to estimate on average per month how many children were admitted on a BTF; 41% (21 of 51) of dietitians reported that on average there are one to five children admitted on a BTF. There was no significant difference in the number of children admitted on a BTF between a specialist and a general children's hospital (χ2 statistic = 4.96, p value < 0.08). The number of dietitians who had clinical guidelines to support children admitted on a BTF was 49% (25 of 51). Specialist children's hospitals were more likely to have a clinical guideline compared with a general hospital (χ2 statistic = 6.348, p value = 0.01). However, only 18 of 51 (35%) dietitians reported being confident or very confident to review a child on a BTF. The most common perceived benefit was that parents/carers could incorporate family foods into their child's diet. 26% reported that a varied diet was beneficial in relation to the gut microbiome. If a BTF was contraindicated for children admitted to a hospital (immunocompromised, post‐pyloric feeding or intensive care), 49 of 51 (96%) dietitians reported they would use an enteral formula with food‐derived ingredients (Compleat paediatric—Nestle Health Science) as an alternative to a BTF.Conclusion: BTF continues to grow in popularity. Our survey reported that children on BTF are frequently admitted to the hospital. There is growing evidence to support BTF in relation to family psychosocial health and feed tolerance. Dietitians must keep abreast of this fast‐evolving area practice to ensure that they are the experts in BTF. When a BTF is contraindicated, an enteral formula with food‐derived ingredients is a suitable alternative. Issues such as microbial contamination, nutritional composition, and adequacy of diluted BTF need further exploration.


  • Open Access

    The impact of an enteral formula with food‐derived ingredients on dietetic practice at a specialist children's hospital in the UK: Retrospective study

    by Graeme O'COnnor, Angela Camacho Velandia, Zoltan Hartfiel Capriles

    Background: Blended tube feeds are reported to be better tolerated in some children compared to standard commercial enteral formulas, allowing children to normalise feeding by having similar foods as the rest of the family. However, a blended tube feed is contraindicated in patients who are immunocompromised or require post‐pyloric feeding as a result of a food safety risk. Other contraindications for blended diet include children who require continuous pump feeding via gastrostomy or nasogastric feeding tube (< 12 Fr) and fluid restrictions. To meet the demands of consumers, manufacturers have developed enteral formulas with food‐derived ingredients (EFI). Commercially available EFIs are relatively novel in the UK. The present study aimed to monitor the implementation of an EFI by dietitians in a specialist children's hospital.Methods: A single‐centre retrospective study was conducted to monitor the dietetic practice of commencing a commercially available EFI (Compleat® paediatric; Nestlé Health Science; 1.2 kcal/ml with 14% food‐derived ingredients). Using electronic medical notes, data were collected on all children who commenced an EFI via an enteral feeding tube in a specialist paediatric hospital between August 2022 and December 2023. Data were gathered on demographics (age, sex and primary diagnosis), anthropometric measurements (weight‐for‐age Z‐score and height‐for‐age Z‐score), feed regimens (feed volume, feeding route, mode of feeding [continuous, bolus]), gastrointestinal symptoms (gastro‐oesophageal reflux, vomiting, abdominal discomfort, constipation and loose stools) and geographical discharge area for children on home enteral nutrition.Results: Seventy children were included in the analysis. The mean ± SD age was 4.7 ± 6 years. The median admission weight‐for‐age Z‐score was −1.50. The most common primary diagnosis was a neurological impairment in 37/70 (47%) children. Most children were fed via a percutaneous endoscopic gastrostomy 31/70 (44%) and 8/70 (11%) of the children fed directly into the jejunum. The most common reason being gastrointestinal symptoms, 58/70 (83%). The most common gastrointestinal symptom reported before commencing an EFI was loose stools in 22/58 (38%) children. Within 7 days of commencing an EFI, there was reported improvement in gastrointestinal symptoms in all categories. In total, 42/70 children were discharged on an EFI.Conclusions: In our specialist children's hospital, EFI is primarily implemented by dietitians in children who are already established on an enteral formula displaying gastrointestinal symptoms. However, dietitians are increasingly implementing an EFI as their first‐line whole protein enteral formula. Furthermore, an EFI was also implemented as a compromise to a blended diet.


  • Open Access

    The impact of low‐energy, partially hydrolysed enteral formula on gastrointestinal symptoms and weight in children with neurological impairment: a multicentre retrospective study

    by Graeme O'COnnor, Martha Van Der Linde, Zoltan Hartfiel Capriles

    Background: Neurological impairment (NI) relates to disorders of the central nervous system. The specific aetiology of NI varies but includes genetic, congenital abnormalities or brain injury. In children with severe NI, feeding impairments can lead to undernutrition, and some children require a feeding tube. Although tube feeding improves overall nutritional status, it has also been associated with excess body fat. Commercially available enteral formulas that are low in energy, hydrolysed and nutritionally adequate for protein and micronutrients are available to mitigate gastrointestinal symptoms and obesity.Methods: This is a retrospective multicentre study of children who attended NI clinics between January 2022 and July 2023. Data were collected before and 1 month after receiving a low‐energy, partially hydrolysed enteral formula (0.6 kcal/mL) on demographic data (age, sex, ethnicity and NI diagnosis), anthropometric measurements (weight, height, weight‐for‐age Z‐score, height‐for‐age Z‐score, body mass index [BMI] Z‐score) and feed regimen (feed volume, total fluids and type of formula/supplements).Results: Dietitians collected data on 28 children, the median age was 7 years (interquartile range [IQR] 3, 8). The most frequently recorded NI was cerebral palsy, in 13 of 28 children (48%). Before the formula switch, the most frequently reported gastrointestinal symptom was constipation, in 13 of 28 children. Within 1 month of switching to a low‐energy, hydrolysed formula, 10 of the 13 (77%) children reported an improvement in constipation. Before the formula switch, all 28 children were experiencing excessive weight gain. After the formula was switched to low‐energy, hydrolysed formula, dietitians reported that 20 of the 28 (76%) children's weight either stabilised or reduced after 1 month. There was no statistically significant difference in weight‐for‐age Z‐score or BMI Z‐scores postswitch of formula (p‐value 0.1 and 0.09, respectively). Fibre intake increased significantly from 3.3 to 8.1 g/day (p‐value < 0.01) after formula switch. The number of children whose feed regimens were simplified after switching to a low‐energy, partially hydrolysed formula was 24 of 28 (91%).Conclusions: Children with an NI who have gastrointestinal symptoms may benefit from a low‐energy, hydrolysed enteral formula to maximise feed tolerance and promote healthy weight gain. In addition, changing to a low‐energy, hydrolysed formula may simplify feed regimens by eliminating the need for additional electrolytes, multivitamins and fluid boluses. Healthcare professionals should be knowledgeable about the effectiveness and availability of a low‐energy, hydrolysed formula.